| Financial Year |
March 31 2023 |
| Monetary Funds |
28,824,856.71 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
42,625,317.69 |
| Advances to Suppliers |
108,852.27 |
| Other Receivables |
791,856.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
29,387,619.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,872,946.83 |
| Total Current Assets |
635,195,824.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
146,380,566.49 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
31,233,084.20 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,425,839.40 |
| Deferred Income Tax Assets |
1,203,712.46 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
186,279,416.70 |
| Total Assets |
821,475,241.12 |
| Short-Term Loans |
10,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
62,757,196.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
244,647.52 |
| Taxes Payable |
971,723.59 |
| Interest Payable |
-- |
| Dividend Payable |
1,356,741.40 |
| Other payables |
61,023,982.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,937,974.00 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
525,373,373.56 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,849,682.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,746,026.20 |
| Total Liabilities |
532,119,399.76 |
| Paid-In Capital(Or Share Stock) |
222,147,539.00 |
| Capital Surplus |
74,686,282.19 |
| Surplus Reserve |
13,763,536.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-132,899,018.76 |
| Minority Stockholder's Interest |
111,657,502.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
177,698,338.64 |
| Owner's Equity（Stockholder's Equity） |
289,355,841.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
821,475,241.12 |
